Alkeon Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-699,695
| Closed | -$22.2M | – | 107 |
|
|
2023
Q2 | $22.2M | Sell |
699,695
-36,826
| -5% | -$1.17M | 0.04% | 72 |
|
|
2023
Q1 | $18M | Sell |
736,521
-327,880
| -31% | -$8M | 0.04% | 75 |
|
|
2022
Q4 | $33.6M | Sell |
1,064,401
-104,195
| -9% | -$3.29M | 0.13% | 68 |
|
|
2022
Q3 | $33M | Sell |
1,168,596
-42,383
| -3% | -$1.2M | 0.11% | 81 |
|
|
2022
Q2 | $32M | Sell |
1,210,979
-486,397
| -29% | -$12.9M | 0.09% | 80 |
|
|
2022
Q1 | $59.4M | Sell |
1,697,376
-211,659
| -11% | -$7.41M | 0.12% | 81 |
|
|
2021
Q4 | $61.9M | Sell |
1,909,035
-1,217,400
| -39% | -$39.5M | 0.11% | 84 |
|
|
2021
Q3 | $92.2M | Buy |
3,126,435
+480,000
| +18% | +$14.2M | 0.16% | 85 |
|
|
2021
Q2 | $67.8M | Buy |
2,646,435
+896,435
| +51% | +$23M | 0.1% | 85 |
|
|
2021
Q1 | $24M | Hold |
1,750,000
| – | – | 0.04% | 104 |
|
|
2020
Q4 | $29M | Buy |
+1,750,000
| New | +$29M | 0.05% | 103 |
|